Highlights
KLSE: LUXCHEM (5143)       LUXCHEM CORP BHD MAIN : Industrial Products
Last Price Today's Change   Day's Range   Trading Volume
0.495   0.00 (0.00%)  0.00 - 0.00  0
Trade this stock with T+7 trading account. Find out more.

Financials


Market Cap: 443 Million

Market Cap 443 Million
NOSH 895 Million

Latest Audited Result:  31-Dec-2017

Latest Audited Result: 31-Dec-2017
Announcement Date 05-Apr-2018
Next Audited Result: 31-Dec-2018
Est. Ann. Date: 05-Apr-2019
Est. Ann. Due Date: 29-Jun-2019

Latest Quarter:  30-Jun-2019 [#2]

Latest Quarter: 30-Jun-2019 [#2]
Announcement Date 29-Jul-2019
Next Quarter: 30-Sep-2019
Est. Ann. Date: 25-Oct-2019
Est. Ann. Due Date: 29-Nov-2019
QoQ | YoY   3.06%  |    1.52%

Annual (Unaudited) ( EPS: 4.24, P/E: 10.87 )

Revenue | NP to SH 814,086  |  37,977
RPS | P/RPS 90.96 Cent  |  0.55
EPS | P/E | EY 4.24 Cent  |  10.87  |  9.20%
DPS | DY | Payout % 2.15 Cent  |  7.45%  |  50.71%
NAPS | P/NAPS 0.32  |  1.73
YoY   -6.80%
NP Margin | ROE 4.62%  |  13.45%
F.Y. | Ann. Date 31-Dec-2018  |  15-Feb-2019

T4Q Result ( EPS: 4.26, P/E: 11.63 )

Revenue | NP to SH 809,360  |  38,095
RPS | P/RPS 90.43 Cent  |  0.55
EPS | P/E | EY 4.26 Cent  |  11.63  |  8.60%
DPS | DY | Payout % 2.17 Cent  |  4.38%  |  50.93%
NAPS | P/NAPS 0.33  |  1.50
QoQ | YoY   0.39%  |    0.63%
NP Margin | ROE 4.67%  |  12.87%
F.Y. | Ann. Date 30-Jun-2019  |  29-Jul-2019

Annualized Result ( EPS: 4.36, P/E: 11.36 )

Revenue | NP to SH 781,674  |  38,984
RPS | P/RPS 87.34 Cent  |  0.57
EPS | P/E | EY 4.36 Cent  |  11.36  |  8.80%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   1.53%  |    0.60%
NP Margin | ROE 4.94%  |  13.17%
F.Y. | Ann. Date 30-Jun-2019  |  29-Jul-2019




Show?  YoY % Horiz. %

Last 10 FY Result
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 781,674 809,360 814,086 806,683 701,549 686,754 603,522 524,937 496,877 498,933 399,823 305,308 11.51%
  YoY % -3.42% -0.58% 0.92% 14.99% 2.15% 13.79% 14.97% 5.65% -0.41% 24.79% 30.96% -
  Horiz. % 256.03% 265.10% 266.64% 264.22% 229.78% 224.94% 197.68% 171.94% 162.75% 163.42% 130.96% 100.00%
PBT 52,026 50,197 49,880 55,774 59,078 54,397 29,578 26,170 29,367 30,217 28,046 25,764 7.61%
  YoY % 3.64% 0.64% -10.57% -5.59% 8.61% 83.91% 13.02% -10.89% -2.81% 7.74% 8.86% -
  Horiz. % 201.93% 194.83% 193.60% 216.48% 229.30% 211.14% 114.80% 101.58% 113.98% 117.28% 108.86% 100.00%
Tax -13,436 -12,366 -12,231 -14,790 -15,392 -14,802 -7,747 -6,776 -7,416 -7,526 -7,563 -6,631 7.03%
  YoY % -8.65% -1.10% 17.30% 3.91% -3.99% -91.07% -14.33% 8.63% 1.46% 0.49% -14.06% -
  Horiz. % 202.62% 186.49% 184.45% 223.04% 232.12% 223.22% 116.83% 102.19% 111.84% 113.50% 114.06% 100.00%
NP 38,590 37,831 37,649 40,984 43,686 39,595 21,831 19,394 21,951 22,691 20,483 19,133 7.81%
  YoY % 2.01% 0.48% -8.14% -6.19% 10.33% 81.37% 12.57% -11.65% -3.26% 10.78% 7.06% -
  Horiz. % 201.69% 197.73% 196.78% 214.21% 228.33% 206.95% 114.10% 101.36% 114.73% 118.60% 107.06% 100.00%
NP to SH 38,984 38,095 37,977 40,747 43,499 39,735 21,961 19,648 22,041 22,708 20,483 19,133 7.91%
  YoY % 2.33% 0.31% -6.80% -6.33% 9.47% 80.93% 11.77% -10.86% -2.94% 10.86% 7.06% -
  Horiz. % 203.75% 199.11% 198.49% 212.97% 227.35% 207.68% 114.78% 102.69% 115.20% 118.68% 107.06% 100.00%
Tax Rate 25.83 % 24.63 % 24.52 % 26.52 % 26.05 % 27.21 % 26.19 % 25.89 % 25.25 % 24.91 % 26.97 % 25.74 % -0.54%
  YoY % 4.87% 0.45% -7.54% 1.80% -4.26% 3.89% 1.16% 2.53% 1.36% -7.64% 4.78% -
  Horiz. % 100.35% 95.69% 95.26% 103.03% 101.20% 105.71% 101.75% 100.58% 98.10% 96.78% 104.78% 100.00%
Total Cost 743,084 771,529 776,437 765,699 657,863 647,159 581,691 505,543 474,926 476,242 379,340 286,175 11.72%
  YoY % -3.69% -0.63% 1.40% 16.39% 1.65% 11.25% 15.06% 6.45% -0.28% 25.54% 32.56% -
  Horiz. % 259.66% 269.60% 271.32% 267.56% 229.88% 226.14% 203.26% 176.66% 165.96% 166.42% 132.56% 100.00%
Net Worth 295,951 295,951 282,432 256,218 76,042 191,822 156,063 144,321 137,022 125,803 113,072 102,651 11.89%
  YoY % 0.00% 4.79% 10.23% 236.94% -60.36% 22.91% 8.14% 5.33% 8.92% 11.26% 10.15% -
  Horiz. % 288.31% 288.31% 275.14% 249.60% 74.08% 186.87% 152.03% 140.59% 133.48% 122.55% 110.15% 100.00%
Dividend
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 17,408 19,402 19,256 33,060 19,010 17,080 15,606 10,401 11,092 11,672 10,397 9,095 8.69%
  YoY % -10.28% 0.76% -41.75% 73.91% 11.30% 9.44% 50.04% -6.23% -4.97% 12.26% 14.31% -
  Horiz. % 191.40% 213.32% 211.71% 363.47% 209.01% 187.78% 171.58% 114.36% 121.95% 128.33% 114.31% 100.00%
Div Payout % 44.66 % 50.93 % 50.71 % 81.14 % 43.70 % 42.98 % 71.06 % 52.94 % 50.33 % 51.40 % 50.76 % 47.54 % 0.72%
  YoY % -12.31% 0.43% -37.50% 85.68% 1.68% -39.52% 34.23% 5.19% -2.08% 1.26% 6.77% -
  Horiz. % 93.94% 107.13% 106.67% 170.68% 91.92% 90.41% 149.47% 111.36% 105.87% 108.12% 106.77% 100.00%
Equity
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 295,951 295,951 282,432 256,218 76,042 191,822 156,063 144,321 137,022 125,803 113,072 102,651 11.89%
  YoY % 0.00% 4.79% 10.23% 236.94% -60.36% 22.91% 8.14% 5.33% 8.92% 11.26% 10.15% -
  Horiz. % 288.31% 288.31% 275.14% 249.60% 74.08% 186.87% 152.03% 140.59% 133.48% 122.55% 110.15% 100.00%
NOSH 870,445 870,445 855,857 826,511 271,579 262,769 260,106 130,019 130,497 129,694 129,968 129,938 23.28%
  YoY % 0.00% 1.70% 3.55% 204.34% 3.35% 1.02% 100.05% -0.37% 0.62% -0.21% 0.02% -
  Horiz. % 669.89% 669.89% 658.66% 636.08% 209.01% 202.23% 200.18% 100.06% 100.43% 99.81% 100.02% 100.00%
Ratio Analysis
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 4.94 % 4.67 % 4.62 % 5.08 % 6.23 % 5.77 % 3.62 % 3.69 % 4.42 % 4.55 % 5.12 % 6.27 % -3.33%
  YoY % 5.78% 1.08% -9.06% -18.46% 7.97% 59.39% -1.90% -16.52% -2.86% -11.13% -18.34% -
  Horiz. % 78.79% 74.48% 73.68% 81.02% 99.36% 92.03% 57.74% 58.85% 70.49% 72.57% 81.66% 100.00%
ROE 13.17 % 12.87 % 13.45 % 15.90 % 57.20 % 20.71 % 14.07 % 13.61 % 16.09 % 18.05 % 18.11 % 18.64 % -3.56%
  YoY % 2.33% -4.31% -15.41% -72.20% 176.20% 47.19% 3.38% -15.41% -10.86% -0.33% -2.84% -
  Horiz. % 70.65% 69.05% 72.16% 85.30% 306.87% 111.11% 75.48% 73.02% 86.32% 96.83% 97.16% 100.00%
Per Share
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 89.80 92.98 95.12 97.60 258.32 261.35 232.03 403.74 380.76 384.70 307.63 234.96 -9.55%
  YoY % -3.42% -2.25% -2.54% -62.22% -1.16% 12.64% -42.53% 6.04% -1.02% 25.05% 30.93% -
  Horiz. % 38.22% 39.57% 40.48% 41.54% 109.94% 111.23% 98.75% 171.83% 162.05% 163.73% 130.93% 100.00%
EPS 4.48 4.38 4.44 4.93 5.34 15.12 8.45 7.56 16.89 17.45 15.76 14.72 -12.46%
  YoY % 2.28% -1.35% -9.94% -7.68% -64.68% 78.93% 11.77% -55.24% -3.21% 10.72% 7.07% -
  Horiz. % 30.43% 29.76% 30.16% 33.49% 36.28% 102.72% 57.40% 51.36% 114.74% 118.55% 107.07% 100.00%
DPS 2.00 2.25 2.25 4.00 7.00 6.50 6.00 8.00 8.50 9.00 8.00 7.00 -11.84%
  YoY % -11.11% 0.00% -43.75% -42.86% 7.69% 8.33% -25.00% -5.88% -5.56% 12.50% 14.29% -
  Horiz. % 28.57% 32.14% 32.14% 57.14% 100.00% 92.86% 85.71% 114.29% 121.43% 128.57% 114.29% 100.00%
NAPS 0.3400 0.3400 0.3300 0.3100 0.2800 0.7300 0.6000 1.1100 1.0500 0.9700 0.8700 0.7900 -9.24%
  YoY % 0.00% 3.03% 6.45% 10.71% -61.64% 21.67% -45.95% 5.71% 8.25% 11.49% 10.13% -
  Horiz. % 43.04% 43.04% 41.77% 39.24% 35.44% 92.41% 75.95% 140.51% 132.91% 122.78% 110.13% 100.00%
Adjusted Per Share Value based on latest NOSH - 895,027
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 87.34 90.43 90.96 90.13 78.38 76.73 67.43 58.65 55.52 55.74 44.67 34.11 11.51%
  YoY % -3.42% -0.58% 0.92% 14.99% 2.15% 13.79% 14.97% 5.64% -0.39% 24.78% 30.96% -
  Horiz. % 256.05% 265.11% 266.67% 264.23% 229.79% 224.95% 197.68% 171.94% 162.77% 163.41% 130.96% 100.00%
EPS 4.36 4.26 4.24 4.55 4.86 4.44 2.45 2.20 2.46 2.54 2.29 2.14 7.89%
  YoY % 2.35% 0.47% -6.81% -6.38% 9.46% 81.22% 11.36% -10.57% -3.15% 10.92% 7.01% -
  Horiz. % 203.74% 199.07% 198.13% 212.62% 227.10% 207.48% 114.49% 102.80% 114.95% 118.69% 107.01% 100.00%
DPS 1.95 2.17 2.15 3.69 2.12 1.91 1.74 1.16 1.24 1.30 1.16 1.02 8.63%
  YoY % -10.14% 0.93% -41.73% 74.06% 10.99% 9.77% 50.00% -6.45% -4.62% 12.07% 13.73% -
  Horiz. % 191.18% 212.75% 210.78% 361.76% 207.84% 187.25% 170.59% 113.73% 121.57% 127.45% 113.73% 100.00%
NAPS 0.3307 0.3307 0.3156 0.2863 0.0850 0.2143 0.1744 0.1612 0.1531 0.1406 0.1263 0.1147 11.90%
  YoY % 0.00% 4.78% 10.23% 236.82% -60.34% 22.88% 8.19% 5.29% 8.89% 11.32% 10.11% -
  Horiz. % 288.32% 288.32% 275.15% 249.61% 74.11% 186.84% 152.05% 140.54% 133.48% 122.58% 110.11% 100.00%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date AQR T4Q 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 0.5150 0.5150 0.5200 0.7550 1.4700 1.6600 0.8200 1.2900 1.2500 1.0100 1.0500 1.0500 -
P/RPS 0.57 0.55 0.55 0.77 0.57 0.64 0.35 0.32 0.33 0.26 0.34 0.45 2.25%
  YoY % 3.64% 0.00% -28.57% 35.09% -10.94% 82.86% 9.38% -3.03% 26.92% -23.53% -24.44% -
  Horiz. % 126.67% 122.22% 122.22% 171.11% 126.67% 142.22% 77.78% 71.11% 73.33% 57.78% 75.56% 100.00%
P/EPS 11.50 11.77 11.72 15.31 9.18 10.98 9.71 8.54 7.40 5.77 6.66 7.13 5.67%
  YoY % -2.29% 0.43% -23.45% 66.78% -16.39% 13.08% 13.70% 15.41% 28.25% -13.36% -6.59% -
  Horiz. % 161.29% 165.08% 164.38% 214.73% 128.75% 154.00% 136.19% 119.78% 103.79% 80.93% 93.41% 100.00%
EY 8.70 8.50 8.53 6.53 10.90 9.11 10.30 11.71 13.51 17.34 15.01 14.02 -5.37%
  YoY % 2.35% -0.35% 30.63% -40.09% 19.65% -11.55% -12.04% -13.32% -22.09% 15.52% 7.06% -
  Horiz. % 62.05% 60.63% 60.84% 46.58% 77.75% 64.98% 73.47% 83.52% 96.36% 123.68% 107.06% 100.00%
DY 3.88 4.37 4.33 5.30 4.76 3.92 7.32 6.20 6.80 8.91 7.62 6.67 -4.68%
  YoY % -11.21% 0.92% -18.30% 11.34% 21.43% -46.45% 18.06% -8.82% -23.68% 16.93% 14.24% -
  Horiz. % 58.17% 65.52% 64.92% 79.46% 71.36% 58.77% 109.75% 92.95% 101.95% 133.58% 114.24% 100.00%
P/NAPS 1.51 1.51 1.58 2.44 5.25 2.27 1.37 1.16 1.19 1.04 1.21 1.33 1.93%
  YoY % 0.00% -4.43% -35.25% -53.52% 131.28% 65.69% 18.10% -2.52% 14.42% -14.05% -9.02% -
  Horiz. % 113.53% 113.53% 118.80% 183.46% 394.74% 170.68% 103.01% 87.22% 89.47% 78.20% 90.98% 100.00%
Price Multiplier on Announcement Date
AQR T4Q 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date AQR T4Q 15/02/19 14/02/18 16/02/17 22/02/16 18/02/15 21/02/14 19/02/13 17/02/12 18/02/11 19/02/10 -
Price 0.5300 0.5300 0.5400 0.7750 1.6100 1.8200 0.9050 1.4400 1.2200 1.1100 1.0900 1.0200 -
P/RPS 0.59 0.57 0.57 0.79 0.62 0.70 0.39 0.36 0.32 0.29 0.35 0.43 3.18%
  YoY % 3.51% 0.00% -27.85% 27.42% -11.43% 79.49% 8.33% 12.50% 10.34% -17.14% -18.60% -
  Horiz. % 137.21% 132.56% 132.56% 183.72% 144.19% 162.79% 90.70% 83.72% 74.42% 67.44% 81.40% 100.00%
P/EPS 11.83 12.11 12.17 15.72 10.05 12.04 10.72 9.53 7.22 6.34 6.92 6.93 6.45%
  YoY % -2.31% -0.49% -22.58% 56.42% -16.53% 12.31% 12.49% 31.99% 13.88% -8.38% -0.14% -
  Horiz. % 170.71% 174.75% 175.61% 226.84% 145.02% 173.74% 154.69% 137.52% 104.18% 91.49% 99.86% 100.00%
EY 8.45 8.26 8.22 6.36 9.95 8.31 9.33 10.49 13.84 15.77 14.46 14.44 -6.06%
  YoY % 2.30% 0.49% 29.25% -36.08% 19.74% -10.93% -11.06% -24.21% -12.24% 9.06% 0.14% -
  Horiz. % 58.52% 57.20% 56.93% 44.04% 68.91% 57.55% 64.61% 72.65% 95.84% 109.21% 100.14% 100.00%
DY 3.77 4.25 4.17 5.16 4.35 3.57 6.63 5.56 6.97 8.11 7.34 6.86 -5.38%
  YoY % -11.29% 1.92% -19.19% 18.62% 21.85% -46.15% 19.24% -20.23% -14.06% 10.49% 7.00% -
  Horiz. % 54.96% 61.95% 60.79% 75.22% 63.41% 52.04% 96.65% 81.05% 101.60% 118.22% 107.00% 100.00%
P/NAPS 1.56 1.56 1.64 2.50 5.75 2.49 1.51 1.30 1.16 1.14 1.25 1.29 2.70%
  YoY % 0.00% -4.88% -34.40% -56.52% 130.92% 64.90% 16.15% 12.07% 1.75% -8.80% -3.10% -
  Horiz. % 120.93% 120.93% 127.13% 193.80% 445.74% 193.02% 117.05% 100.78% 89.92% 88.37% 96.90% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  3 people like this.
 
Aero1 Very resilient business model. Sales can up while overheads should remain largely unchanged.
01/05/2019 10:49 AM
Aero1 Good to see export sales pick up.
01/05/2019 10:53 AM
tanflash1314 1. Involve issuance of new type/class of securities ? No
Types of corporate proposal ESOS
Details of corporate proposal Employees' Share Option Scheme
No. of shares issued under this corporate proposal 5,604,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.2400
Par Value($$) (if applicable)

2. Involve issuance of new type/class of securities ? No
Types of corporate proposal ESOS
Details of corporate proposal Employees' Share Option Scheme
No. of shares issued under this corporate proposal 78,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.3400
Par Value($$) (if applicable)


3. Involve issuance of new type/class of securities ? No
Types of corporate proposal ESOS
Details of corporate proposal Employees' Share Option Scheme
No. of shares issued under this corporate proposal 243,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.4900
Par Value($$) (if applicable)


4. Involve issuance of new type/class of securities ? No
Types of corporate proposal ESOS
Details of corporate proposal Employees' Share Option Scheme
No. of shares issued under this corporate proposal 60,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.5300
Par Value($$) (if applicable)
01/05/2019 10:35 PM
tanflash1314 So the 5.6m shares at 0.24 price is really so low. haha.
If really sold on market at the recent price, can direct profit about 1.2 million ringgit.... so good.
01/05/2019 10:39 PM
nkk53 Esos only benefits shareholders and employees. but not for retailers
02/05/2019 10:34 AM
mastermarcus Then pls justify why they drop from sky??
03/05/2019 9:50 AM
WiseVictor Buy all the way down from 0.57 to 0.505 since last year. Finally this undervalue stock show its value =)
03/05/2019 3:19 PM
DickyMe It's not overvalued but manipulated by insiders. They compress the price, distribute to proxies via ESOS to gain vulgar profit.
03/05/2019 4:06 PM
cyeec2000 Any friends who attended their agm can share some information?
03/05/2019 10:57 PM
Patrick13 提高效率·扩展出口·理建冀营收成长10%

化学品制造兼经销公司理建(LUXCHEM,5143,主板工业产品服务组)预计今年将仍具挑战,但仍乐观看待其可稳定发展,并希望可取得10%的营业额增长。

该公司董事经理邓英仕在股东大会后向《星洲财经》表示,今年公司仍面对着美元对马币的波动、原材料价格不定及中美贸易战等挑战。

“像是原油价格从50多美元增至70多美元,已加重部份原材料成本,收窄了赚幅。

若是销售价格再出现恶劣竞争,将进一步侵蚀赚幅。”

对此,他表示,只能提高业务效率及持续的扩展出口市场。

“我们希望取得10%营业额增长,再加上维持赚幅来提高盈利,不过一切还是要看市场情况而定。”

目前理建出口占总营业额约30%,剩余为国内。

东盟增长空间大邓英仕指出,该公司一直在扩展其出口至东盟市场,来取得公司收入增长。

他补充,主要原因是本地人口有限,加上他们已经营多年,市占率不太可能增长。

被问及是否考虑进军其他先进国家,邓英仕认为,先进国家的增长有限,市场供应源已稳定,相反的东盟其他国家的增长空间较大,而且他们也有一定优势。

“此外,化学品的周期性有限,若运输时间过长会出现不稳定性。”

对于是否会增加制造其他化学品,邓英仕指出,这方面的投资向来庞大,像投资人造胶可能要数百亿令吉,所以需要先进行调查,了解市场在哪里和其需求。

但他补充,他们将会探索适合的机会。

“就如之前收购Transform Master一样,若有好得机会,我们将会在考量多方面包括市占率及回报率后才采购。”

根据之前报道,理建2016年收购化学产品制造商Transform Master,为前者制造乳胶化学产品。

https://www.sinchew.com.my/content/content_2048564.html
05/05/2019 10:32 AM
jerret Regain flush up momentum after trade deal faded today, time to add more
07/05/2019 9:15 AM
tanflash1314 a lot of people got trapped. haha
08/05/2019 9:47 PM
tanflash1314 volume not enough. need wait another wave. maybe half year later.
08/05/2019 9:49 PM
chesslim 记住,当别人恐惧时你要贪婪。
08/05/2019 10:58 PM
mastermarcus This company will stagnant for few years and trapped all of you. Break 0.5 is matter of time. Good luck all.
08/05/2019 11:34 PM
Kalaihselvan Krishnan Mastermarcus how you know about this. Seems like you are expert in prediction. Can you predict the bursa closing index on Monday?
10/05/2019 7:15 PM
YAPSS Day 69 Fundamental Daily, YAPSS will be covering Luxchem Corporation Berhad's fundamental via a short animated video. It is solely based on my opinion and I hope it helps :) #YAPSS #FundamentalDaily #LuxchemCorporationBerhad

Click the on the link to find out more: https://youtu.be/6qqUmzoExKA
12/05/2019 10:56 AM
jerret Luxchem will benefit from the failure of us china trade talk, due to streghten of USDollar
18/05/2019 4:21 PM
jerret Benefit in two form
1. Strengthen of USD due to trade war export oriented company
2. Increase in selling of resin, arising from high demand of unsaturated polyester resin from latex glove industries
20/05/2019 12:40 PM
mastermarcus I told it breaks 0.5...in facts yes touching 0.495. Long term price shall be below 0.5. When ppls all the way buy from 0.9-0.7...I watching it with popcorn....below 0.500 only I have interest in this counter. Thanks, I didn’t predict, I am seeing trend.
03/06/2019 11:54 PM
striker888 Sin ga Lin, mastermarcus, ha-ha
13/06/2019 9:19 AM
Superb99 Should monitor this counter from today onwards
14/06/2019 5:55 AM
Superb99 Seems like defending well for t+1
14/06/2019 11:11 PM
Superb99 could be just one day show, drops so much and no support even with small volume, T+2 today, let's see tomorrow
17/06/2019 3:37 PM
Superb99 Zombie counter
18/06/2019 12:26 PM
Patrick13 次季获利将砍半·全球化工龙头巴斯夫大砍全年财测

全球最大化工业者德国巴斯夫集团(BASF)大幅调降全年财测并警告第二季获利将砍半,原因在于中美贸易大战未见缓和,连带影响全球经济放缓与工业生产下滑,导致该公司业绩难逃冲击。

盘中重挫5.3%
朗盛科思创暴跌逾5%

受此消息拖累,巴斯夫9日股价盘中重挫5.3%,每股报59.29欧元。其他同业亦表现不佳,德国朗盛(Lanxess)与科思创(Covestro)双双暴跌逾5%,英国庄信万丰(Johnson Matthey)下挫2.5%。在化工类股领跌之下,Stoxx600欧股指数下跌0.6%。

巴斯夫预估,今年排除特定项目的税息前获利率(EBIT)最多将较去年下跌30%,低于先前预估的年增1%~10%。至于全年营收则从原本预期的年增1%~5%下修至“微幅衰退”。

巴斯夫表示,受到中美贸易冲突持续的影响,全球经济成长降温与工业生产下滑,严重拖累第二季业绩表现,该公司因此下调全年财测。

巴斯夫声明指出:“美国与其他国家的贸易纷争(尤其是中国)迄今未出现缓和迹象。我们认为中美贸易冲突在今年下半年仍无法趋缓,整体而言,不确定因素仍相当多。”

至于第二季财报方面,巴斯夫预期,该季营收将年减4%至152亿欧元,不如分析师预期的159.8亿欧元。

而第二季获利则估计年减47%至10亿欧元,不如市场预期的16亿欧元,主因在于“材料、化学品与农业部门获利远不如去年同期”。

虽然多位分析师日前预测巴斯夫可能下调全年财测,但该公司下修幅度之大仍超乎他们预期。研调机构Bernstein分析师札克曼(Gunther Zechmann)预估,该公司下半年业绩表现可能更惨。

巴斯夫6月时宣布,他们打算在2021年底前裁员6千人,目的在于删减支出,该公司重申该计划维持不变。

汽车消费品电脑晶片亦不妙

巴斯夫的产品被广泛用于汽车、消费品及电脑晶片等众多产业,如今巴斯夫发布获利预警,也使投资人怀疑其他产业的获利情况,欧洲化学与汽车类股9日盘中也跟着巴斯夫股价重挫。

瑞士GAM集团首席经济学者海瑟威指出,原材料及其他景气循环相关业者对未来的财测也将缺乏信心,“这个财报季对巴斯夫和其他公司而言,将挑战十足”。

德国戴姆勒集团两周前下修财测,且是一年内第三度下修。德意志银行本周也宣布全球裁员18,000人。分析师指出,由于德国汽车及化工两大关键产业都情况不佳,预料德国经济不衰退也难。

https://www.sinchew.com.my/content/content_2081562.html
10/07/2019 8:20 PM
Halosam May I know why the esos price is only rm0.24? How come this can happen? The market share is rm0.505 now, they easily make money like that, can report this to bursa? This is really unfair to us, like Chen moi kew, she disposed 2595000 units on 13/6, after that esos on 28/6 4590000 units at the price 0.24, this is sucking our blood, can anyone explain? Or we can sue to bursa there?
15/07/2019 9:11 AM
TP_yes_SL_no esos intends to reward employees who contribute to the company. It appears unfair coz they got it a much lower price but i doubt you can do anything about it. Alternatively you can shun this counter & find other potential ones
15/07/2019 7:28 PM
Patrick13 The only thing you can do is object against this resolution when BOD propose ESOS and seek shareholder approval at the agm.
16/07/2019 10:17 AM
DickyMe "Posted by TP_yes_SL_no > Jul 15, 2019 7:28 PM | Report Abuse
esos intends to reward employees who contribute to the company. It appears unfair coz they got it a much lower price but i doubt you can do anything about it. Alternatively you can shun this counter & find other potential ones"

What they contribute? We cannot see any significant improvement neither in business nor share price.
16/07/2019 10:24 AM
DickyMe "TP_yes_SL_no esos intends to reward employees who contribute to the company. It appears unfair coz they got it a much lower price but i doubt you can do anything about it. Alternatively you can shun this counter & find other potential ones"

Alternatively the company can delist itself. Get lost from Bursa.
16/07/2019 10:41 AM
TP_yes_SL_no DickyMe sadly true.. I did not see their contribution either.
16/07/2019 7:03 PM
Tomatoman79 good lah. meaning company is good to their staff what..
16/07/2019 7:18 PM
Tomatoman79 owh wait wait... giving esos worth RM500k for free is not good. too much!
16/07/2019 7:20 PM
cyeec2000 Non stopped ESOS
23/07/2019 10:41 AM
Aero1 Sad to see the ESOS!
25/07/2019 7:58 PM
Ncm88 Non stop eaos ! Lol
29/07/2019 1:06 PM
Aero1 Export sales saving domestic sales.
Q2 results resilient considering tough environment.
Decent operating cashflow.
29/07/2019 1:38 PM
Patrick13 QR still very resilient.
2nd year shall be better due to contributed by capacity expansion.
29/07/2019 3:55 PM
Aero1 Good return on dividend.
Better than FD.
30/07/2019 10:32 AM
Aero1 Happy to hold more
Defensive and resilient business model.
31/07/2019 1:28 PM
DickyMe How much they pay you to butter up?
31/07/2019 4:58 PM
Aero1 Strong dollar is good when overseas sales are increasing.
01/08/2019 10:32 AM
Aero1 Everyone queuing to buy esos shares
02/08/2019 11:01 AM
Doer This company so good to their staff, good business growth...continue contribute continue grow...
11/08/2019 1:46 AM
WiseVictor The company make a wrong move of ESOS at downtrend market. It is difficult to bring up the stock price if their own people selling off their shares and pressing down the price.
04/09/2019 1:20 PM
Patrick13 Bought at 0.485.
02/10/2019 10:00 AM
PunTatBerSiul Keep in refrigerator.
02/10/2019 6:15 PM
Kakitapau Good volume come in. Any Good news ?
16/10/2019 5:47 PM
Fei Teng Goreng goreng only
17/10/2019 1:34 PM